Inhibitory Antibodies
-
F1637 Anti-CD79b Antibody (Polatuzumab)Summary: Anti-CD79b Antibody (Polatuzumab) -
F1638 Anti-ABCB5 Antibody (Brigham and Women's patent anti-ABCB5)Summary: Anti-ABCB5 Antibody (Brigham and Women's patent anti-ABCB5) -
F1639 Anti-Albumin Antibody (Numab patent anti-HSA)Summary: Anti-Albumin Antibody (Numab patent anti-HSA) -
F1640 Anti-ANGPTL8 Antibody (Regeneron patent anti-ANGPTL8)Summary: Anti-ANGPTL8 Antibody (Regeneron patent anti-ANGPTL8) -
F1641 Anti-C1q Antibody (ANX005)Summary: Anti-C1q Antibody (ANX005) -
F1642 Anti-CDH17/Cadherin-17 Antibody (10C12)Summary: Anti-CDH17/Cadherin-17 Antibody (10C12) -
F1643 Anti-CEACAM6/CD66c Antibody (NEO-201)Summary: Anti-CEACAM6/CD66c Antibody (NEO-201) -
F1644 Anti-Clathrin Heavy Chain/CHC Antibody (Academia Sinica patent anti-Clathrin Heavy Chain)Summary: Anti-Clathrin Heavy Chain/CHC Antibody (Academia Sinica patent anti-Clathrin Heavy Chain) -
F1645 Anti-CLDN6 Antibody (IMAB027)Summary: Anti-CLDN6 Antibody (IMAB027) -
F1646 Anti-Complement C5aR1 Antibody (G2_anti-C5aR)Summary: Anti-Complement C5aR1 Antibody (G2_anti-C5aR)

